Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: Data of the French national observatory for epidemiology of bacterial resistance to antibiotics (ONERBA), 1998-2003;Surveillance de la résistance bactérienne aux antibiotiques dans les bactériémies: Données de l'observatoire national de l'épidémiologie de la résistance bactérienne aux antibiotiques (ONERBA) 1998-2003

Medecine et Maladies Infectieuses

Volumn 35, Issue 6, 2005, Pages 329-334

  Bertrand, X ^a   Costa, Y ^a   Pina, P ^a  

^a Pour Le Conseil Scientifique de l'ONERBA   (France)

Author keywords

Bacteremia; Bacterial resistance; Empiric antibiotherapy

Indexed keywords

AMIKACIN; AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; METICILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HEALTH SURVEY; INFORMATION PROCESSING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 23644455005     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.05.002     Document Type: Article

References (12)

1. D.A. Goldmann, and W.C. Huskins Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide Clin. Infect. Dis. 24 Suppl 1 1997 S139 S145
2. S. Harbarth Nosocomial transmission of antibiotic-resistant micro-organisms Curr. Opin. Infect. Dis. 14 4 2001 437 442
3. S.E. Cosgrove, G. Sakoulas, E.N. Perencevich, M.J. Schwaber, A.W. Karchmer, and Y. Carmeli Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis Clin. Infect. Dis. 36 1 2003 53 59
4. S.E. Cosgrove, K.S. Kaye, G.M. Eliopoulous, and Y. Carmeli Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species Arch. Intern. Med. 162 2 2002 185 190
5. S.E. Cosgrove, and Y. Carmeli The impact of antimicrobial resistance on health and economic outcomes Clin. Infect. Dis. 36 11 2003 1433 1437
6. Vancomycin-resistant Staphylococcus aureus, Pennsylvania, 2002 MMWR Morb. Mortal. Wkly. Rep. 51 40 2002 902
7. Staphylococcus aureus resistant to vancomycin, United States, 2002 MMWR Morb. Mortal. Wkly. Rep. 51 26 2002 565 567
8. D.A. Goldmann, R.A. Weinstein, R.P. Wenzel, O.C. Tablan, R.J. Duma, and R.P. Gaynes Strategies to prevent and control the emergence and spread of antimicrobial-resistant micro-organisms in hospitals. A challenge to hospital leadership JAMA 275 3 1996 234 240
9. C.J. Soussy, G. Carret, J.D. Cavallo, H. Chardon, C. Chidiac, and P. Choutet Antibiogram Committee of the French Microbiology Society. Report 2000-2001 Pathol. Biol. (Paris) 48 9 2000 832 871
10. M.T. Albertini, C. Benoit, L. Berardi, Y. Berrouane, A. Boisivon, and P. Cahen Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study J. Hosp. Infect. 52 2 2002 107 113
11. F. Vandenesch, T. Naimi, M.C. Enright, G. Lina, G.R. Nimmo, and H. Heffernan Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence Emerg. Infect. Dis. 9 8 2003 978 984
12. N. Bruinsma, K.G. Kristinsson, S. Bronzwaer, P. Schrijnemakers, J. Degener, and E. Tiemersma Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe J. Antimicrob. Chemother. 54 6 2004 1045 1050